BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18833664)

  • 1. Inpatient monitoring and prognostic importance of B-type natriuretic peptide.
    Aspromonte N; Valle R; Peacock WF; Vanderheyden M; Maisel A
    Congest Heart Fail; 2008; 14(4 Suppl 1):30-4. PubMed ID: 18833664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.
    Logeart D; Thabut G; Jourdain P; Chavelas C; Beyne P; Beauvais F; Bouvier E; Solal AC
    J Am Coll Cardiol; 2004 Feb; 43(4):635-41. PubMed ID: 14975475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
    Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
    BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure.
    Goonewardena SN; Gemignani A; Ronan A; Vasaiwala S; Blair J; Brennan JM; Shah DP; Spencer KT
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):595-601. PubMed ID: 19356487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure.
    Wong DT; George K; Wilson J; Manlhiot C; McCrindle BW; Adeli K; Kantor PF
    Am J Cardiol; 2011 Feb; 107(4):573-8. PubMed ID: 21295174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of serial assessment of natriuretic peptides in the emergency department for patients with acute decompensated heart failure.
    Disomma S; Magrini L; Pittoni V; Marino R; Peacock WF; Maisel A
    Congest Heart Fail; 2008; 14(4 Suppl 1):21-4. PubMed ID: 18772629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic peptide testing for predicting adverse events following heart failure hospitalization.
    Januzzi JL; Maisel AS; Silver M; Xue Y; DeFilippi C
    Congest Heart Fail; 2012; 18 Suppl 1():S9-S13. PubMed ID: 22891803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of the use of B-type natriuretic peptide levels for risk stratification at discharge in elderly patients with decompensated heart failure.
    Cournot M; Mourre F; Castel F; Ferrières J; Destrac S
    Am Heart J; 2008 Jun; 155(6):986-91. PubMed ID: 18513508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of brain natriuretic Peptide and bioimpedance to guide therapy in heart failure patients.
    Valle R; Aspromonte N
    Contrib Nephrol; 2010; 164():209-216. PubMed ID: 20428005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
    Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
    Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.
    Cheng V; Kazanagra R; Garcia A; Lenert L; Krishnaswamy P; Gardetto N; Clopton P; Maisel A
    J Am Coll Cardiol; 2001 Feb; 37(2):386-91. PubMed ID: 11216951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
    Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
    J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of the prognostic significance of B-type natriuretic peptide levels on admission in patients hospitalized for acute heart failure syndromes.
    Minami Y; Kajimoto K; Sato N; Hagiwara N; Takano T; Mebazaa A;
    Eur J Intern Med; 2016 Jun; 31():41-9. PubMed ID: 26880295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels.
    Valle R; Aspromonte N; Milani L; Peacock FW; Maisel AS; Santini M; Ronco C
    Heart Fail Rev; 2011 Nov; 16(6):519-29. PubMed ID: 21604179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ratio of pro-B-type natriuretic peptide (BNP) to total BNP is decreased in mild, but not severe, acute decompensated heart failure patients: A novel compensatory mechanism for acute heart failure.
    Takahama H; Takashio S; Nishikimi T; Hayashi T; Nagai-Okatani C; Nakagawa Y; Amaki M; Ohara T; Hasegawa T; Sugano Y; Kanzaki H; Yasuda S; Kangawa K; Minamino N; Anzai T
    Int J Cardiol; 2018 May; 258():165-171. PubMed ID: 29544926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
    Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
    Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of natriuretic peptide testing in the evaluation and management of acute decompensated heart failure.
    Chiong JR; Jao GT; Adams KF
    Heart Fail Rev; 2010 Jul; 15(4):275-91. PubMed ID: 19360469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.